BAD logo

B.A.D. ETF (BAD) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, B.A.D. ETF (BAD) es una empresa del sector Financial Services valorada en 0. Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 44/100

B.A.D. ETF (BAD) Perfil de Servicios Financieros

Año de la oferta pública inicial (OPI)2021

B.A.D. ETF offers targeted exposure to specific sectors, including betting, alcohol, Canadian cannabis, and pharmaceuticals, through a passive indexing strategy. As a non-diversified fund, it aims to replicate the performance of its underlying index, appealing to investors seeking concentrated exposure to these industries.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

B.A.D. ETF presents a targeted investment vehicle for those seeking exposure to the betting, alcohol, cannabis, and pharmaceutical sectors. The fund's passive management approach aims to replicate the performance of its underlying index, offering a cost-effective way to invest in these industries. Key value drivers include the growth potential of the cannabis market, the resilience of the alcohol and pharmaceutical sectors, and the expansion of legalized betting and gambling. However, investors should be aware of the risks associated with the fund's non-diversified nature, which makes it susceptible to sector-specific downturns and regulatory changes. The ETF's performance is directly tied to the performance of the companies within its index, making it crucial to monitor the trends and developments within these industries.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • B.A.D. ETF focuses on a niche investment strategy, targeting betting, alcohol, cannabis, and pharmaceutical sectors.
  • The fund operates with a passive management approach, aiming to replicate the performance of its underlying index.
  • B.A.D. ETF is non-diversified, concentrating its investments in specific sectors, which can lead to higher volatility.
  • The fund's performance is directly linked to the growth and regulatory landscape of the betting, alcohol, cannabis, and pharmaceutical industries.
  • B.A.D. ETF offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.

Competidores y Pares

Fortalezas

  • Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
  • Passive management approach.
  • Rules-based index.
  • Simplified way to gain exposure to a basket of companies within these sectors.

Debilidades

  • Non-diversified nature.
  • Susceptibility to sector-specific downturns.
  • Reliance on regulatory landscape.
  • Potential for high volatility.

Catalizadores

  • Upcoming: Further legalization of cannabis in additional states and countries.
  • Ongoing: Expansion of online betting and gambling markets.
  • Ongoing: Pharmaceutical companies within the fund achieving FDA approvals for new drugs.

Riesgos

  • Potential: Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.
  • Potential: Economic downturns reducing consumer spending on these products.
  • Ongoing: High volatility due to the fund's non-diversified nature.
  • Ongoing: Negative sentiment towards specific sectors affecting investor demand.

Oportunidades de crecimiento

  • Expansion of Legalized Betting and Gambling: The ongoing legalization of sports betting and online gambling in various jurisdictions presents a significant growth opportunity for B.A.D. ETF. As more states and countries legalize these activities, the companies within the ETF's betting and gambling sector are likely to experience increased revenue and profitability. This trend is expected to continue over the next 3-5 years, driving growth for the ETF. The global online gambling market is projected to reach $127.3 billion by 2027, according to a report by Allied Market Research.
  • Growth of the Cannabis Market: The increasing legalization and acceptance of cannabis for both medical and recreational purposes is a major growth driver for B.A.D. ETF. The ETF's exposure to Canadian cannabis companies allows it to capitalize on the expanding cannabis market. As more countries and regions legalize cannabis, the companies within the ETF's portfolio are expected to benefit from increased demand and market opportunities. The global legal cannabis market is projected to reach $90.4 billion by 2026, according to a report by Grand View Research.
  • Resilience of the Alcohol Sector: The alcohol industry is known for its resilience, even during economic downturns. B.A.D. ETF's exposure to alcohol companies provides a stable source of revenue and growth potential. The demand for alcoholic beverages remains consistent, making this sector a reliable component of the ETF's portfolio. The global alcoholic beverages market is projected to reach $1.6 trillion by 2025, according to a report by Statista.
  • Pharmaceutical Sector Innovation: The pharmaceutical industry is constantly innovating, with new drugs and therapies being developed to address various health conditions. B.A.D. ETF's exposure to pharmaceutical companies allows it to benefit from these advancements. The development and commercialization of new drugs can drive significant revenue growth for the companies within the ETF's portfolio. The global pharmaceutical market is projected to reach $1.57 trillion by 2028, according to a report by Fortune Business Insights.
  • Increased Investor Demand for Thematic ETFs: The growing popularity of thematic ETFs, which focus on specific sectors or trends, presents a growth opportunity for B.A.D. ETF. Investors are increasingly seeking targeted exposure to specific areas of the market, and thematic ETFs provide a convenient way to achieve this. As more investors allocate capital to thematic ETFs, B.A.D. ETF is likely to benefit from increased inflows and asset growth. The global thematic ETF market is projected to reach $400 billion by 2027, according to a report by ETFGI.

Oportunidades

  • Expansion of legalized betting and gambling.
  • Growth of the cannabis market.
  • Pharmaceutical sector innovation.
  • Increased investor demand for thematic ETFs.

Amenazas

  • Regulatory changes in betting, alcohol, cannabis, and pharmaceutical sectors.
  • Economic downturns affecting consumer spending on these products.
  • Increased competition from other thematic ETFs.
  • Negative sentiment towards specific sectors.

Ventajas competitivas

  • First-mover advantage in offering a unique combination of sector exposure.
  • Passive management approach provides cost-effectiveness.
  • Rules-based index ensures transparency and consistency.

Acerca de BAD

B.A.D. ETF operates as a passively managed fund, designed to replicate the performance of a specific rules-based index. The fund's investment strategy focuses on providing exposure to a unique combination of sectors: betting or gambling companies, alcohol companies, Canadian cannabis companies (defined as those listed on Canadian exchanges, domiciled in Canada, or primarily operating there), and pharmaceutical companies. By tracking this index, B.A.D. ETF aims to deliver returns that mirror the collective performance of these industries, before accounting for fees and expenses. The fund's non-diversified nature means that its performance is heavily reliant on the performance of these specific sectors, making it a targeted investment vehicle for those with a particular interest in these areas. The fund's structure allows investors to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks, offering a simplified approach to investing in these industries.

Qué hacen

  • Tracks a rules-based index focused on betting, alcohol, cannabis, and pharmaceutical companies.
  • Provides exposure to a portfolio of companies in specific sectors.
  • Offers a passive management approach, aiming to replicate the index's performance.
  • Invests in companies listed on Canadian exchanges, domiciled in Canada, or primarily operating in Canada within the cannabis sector.
  • Offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.
  • Operates as a non-diversified fund, concentrating its investments in specific sectors.

Modelo de Negocio

  • Generates revenue through management fees charged to investors.
  • Aims to replicate the performance of its underlying index, providing returns to investors.
  • Attracts investors seeking targeted exposure to betting, alcohol, cannabis, and pharmaceutical sectors.

Contexto de la Industria

B.A.D. ETF operates within the asset management industry, specifically focusing on thematic ETFs that target niche sectors. The ETF's strategy of investing in betting, alcohol, cannabis, and pharmaceutical companies positions it within industries experiencing varying degrees of growth and regulatory scrutiny. The competitive landscape includes other thematic ETFs, such as ERM, GERM, GFOF, GPOW, and HART, that may focus on similar or overlapping sectors. The asset management industry is characterized by increasing demand for specialized investment products, driven by investors seeking targeted exposure to specific market trends and sectors.

Clientes Clave

  • Retail investors seeking exposure to specific sectors.
  • Institutional investors looking for targeted investment strategies.
  • Investors interested in the betting, alcohol, cannabis, and pharmaceutical industries.
Confianza de la IA: 71% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de B.A.D. ETF (BAD): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para BAD.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para BAD.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para BAD.

MoonshotScore

44/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de BAD en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Lo Que los Inversores Preguntan Sobre B.A.D. ETF (BAD)

¿Cuáles son los factores clave para evaluar BAD?

B.A.D. ETF (BAD) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).. Riesgo principal a monitorear: Potential: Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de BAD?

BAD actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de BAD?

Los precios de BAD se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre BAD?

La cobertura de analistas para BAD incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en BAD?

Las categorías de riesgo para BAD incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de BAD?

La relación P/E para BAD compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está BAD sobrevalorada o infravalorada?

Determinar si B.A.D. ETF (BAD) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de BAD?

B.A.D. ETF (BAD) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • The fund's performance is heavily reliant on the performance of the specific sectors it targets.
  • Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance.
Fuentes de datos

Popular Stocks